Nanomedicines for Breast Cancer Theranostics (notice n° 1331699)
[ vue normale ]
000 -LEADER | |
---|---|
fixed length control field | 01815cam a2200289zu 4500 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | FRCYB88966169 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250429184430.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 250429s2020 fr | o|||||0|0|||eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9780128200162 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | FRCYB88966169 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | FR-PaCSA |
Language of cataloging | en |
Transcribing agency | |
Description conventions | rda |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Thorat, Nanasaheb D. |
245 01 - TITLE STATEMENT | |
Title | Nanomedicines for Breast Cancer Theranostics |
Statement of responsibility, etc. | ['Thorat, Nanasaheb D.', 'Bauer, Joanna'] |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Name of producer, publisher, distributor, manufacturer | Elsevier Science |
Date of production, publication, distribution, manufacture, or copyright notice | 2020 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | p. |
336 ## - CONTENT TYPE | |
Content type code | txt |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media type code | c |
Source | rdamdedia |
338 ## - CARRIER TYPE | |
Carrier type code | c |
Source | rdacarrier |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Nanomedicines for Breast Cancer Theranostics addresses the translational aspects and clinical perspectives of breast cancer nanomedicine from a multidisciplinary perspective. The book summarizes research efforts at the preclinical and clinical stage of nanostructures and nanomedicine for dealing with the important challenge of nanomedicine translation in breast cancer theranostics. This book is an important resource for those working in both academia and industry, focusing on hot topics in biomaterials, biomedical engineering, drug delivery and oncology. - Shows how the discovery of new nanomedicines is leading directly to an increase in the early-stage diagnosis of breast cancer - Includes coverage of breast cancer nanomedicine standardization and characterization, highlighting newly developed treatments, diagnostics and treatment monitoring tools - Explains why the design of nanobiomaterials make them effective drug carriers when treating breast cancer |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | |
700 0# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Thorat, Nanasaheb D. |
700 0# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bauer, Joanna |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Access method | Cyberlibris |
Uniform Resource Identifier | <a href="https://international.scholarvox.com/netsen/book/88966169">https://international.scholarvox.com/netsen/book/88966169</a> |
Electronic format type | text/html |
Host name |
Pas d'exemplaire disponible.
Réseaux sociaux